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Abstract
Background: Antiretroviral therapy has changed the natural history of human immunodeficiency virus (HIV) infection in
developed countries, where it has become a chronic disease. This clinical scenario requires a new approach to simplify
follow-up appointments and facilitate access to healthcare professionals.
Methodology: We developed a new internet-based home care model covering the entire management of chronic HIV-
infected patients. This was called Virtual Hospital. We report the results of a prospective randomised study performed over
two years, comparing standard care received by HIV-infected patients with Virtual Hospital care. HIV-infected patients with
access to a computer and broadband were randomised to be monitored either through Virtual Hospital (Arm I) or through
standard care at the day hospital (Arm II). After one year of follow up, patients switched their care to the other arm. Virtual
Hospital offered four main services: Virtual Consultations, Telepharmacy, Virtual Library and Virtual Community. A technical
and clinical evaluation of Virtual Hospital was carried out.
Findings: Of the 83 randomised patients, 42 were monitored during the first year through Virtual Hospital (Arm I) and 41
through standard care (Arm II). Baseline characteristics of patients were similar in the two arms. The level of technical
satisfaction with the virtual system was high: 85% of patients considered that Virtual Hospital improved their access to
clinical data and they felt comfortable with the videoconference system. Neither clinical parameters [level of CD4+ T
lymphocytes, proportion of patients with an undetectable level of viral load (p = 0.21) and compliance levels .90%
(p = 0.58)] nor the evaluation of quality of life or psychological questionnaires changed significantly between the two types
of care.
Conclusions: Virtual Hospital is a feasible and safe tool for the multidisciplinary home care of chronic HIV patients.
Telemedicine should be considered as an appropriate support service for the management of chronic HIV infection.
Trial Registration: Clinical-Trials.gov: NCT01117675.
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Introduction
Since the appearance of highly active antiretroviral treatments
(HAART) the process of HIV/AIDS becoming a chronic disease
in the industrialised world has led to a dramatic change in the
illness paradigm [1]. Patients who would previously have been
terminally ill are now chronically ill, and palliative care has
become chronic care [2,3]. This situation requires a completely
new approach to care of the HIV/AIDS patient.
For patients, a chronic disease course means visiting their
hospital every three months, first to perform a blood test, second
for the follow-up appointment and, finally, to collect their
medication from the hospital pharmacy. This clinical routine
can interfere with patients’ attempts to return to normality in their
daily lives, and may create problems with employers due to work
absences [4,5]. In addition, patients need to be closely monitored
in order to maximise their adherence to medication, and therefore
prevent the development of resistance.
For the infectious diseases physician the follow-up of a chronic
HIV patient has become easier, because these patients are
relatively young, show few comorbidities and do not require
complex monitoring, simply a blood test and routine appointments
every three months to check on results.
However, there is still no cure for the infection and the number
of chronic HIV-infected patients is increasing year by year,
thereby placing greater demands on healthcare systems. As a result
there is a need to optimise health resources, both in terms of
infrastructure and staffing levels.
In this regard, ideas about how to approach this situation may
be gained by looking at other chronic diseases such as diabetes [6–
9], chronic obstructive pulmonary disease [10–12] or congestive
heart failure [13–15], which have made use of telemedicine for
several years now. Research has shown that a multidisciplinary
management programme and home-based intervention can
reduce hospital readmission rates and length of hospital stay in
patients with chronic cardiac disease [16–18], as well as improving
their quality of life [19–21]. In the case of diabetes, telemedicine
allows the frequent transmission of blood glucose values to
healthcare providers, thereby enabling them to modify the medical
regime and/or diet so as to improve metabolic control [22–25].
Telecare involves the delivery of health and social care to
individuals within the home or wider community, with the support
of systems enabled by information technology [26]. It introduces
new forms of assessment designed to improve the quality and
variety of information which clinicians have about a patient’s
health status. Measures of functional status and quality of life, in
addition to physiological monitoring, can be translated into
accurate predictors of health risk, and they can be combined with
electronic alarm systems to initiate an appropriate course of
action. This information is invaluable in identifying and treating
problems, sometimes at an earlier stage [27].
A further aspect is that the coordination of the care team and
the involvement of patients in their own care [28] seem to be
factors of great importance for good chronic disease management
[29]. A multidisciplinary care team is also desirable in a disease
such as HIV/AIDS, where psychological and social factors have
an increasing influence on a patient’s health status. Indeed,
chronic care requires a holistic model that integrates doctors,
psychologists, nurses, social workers and pharmacists into the same
team, of which the patient should also be seen as a member [30].
Telemedicine is attractive to physicians because it offers them
the possibility of reaching all those patients who need their advice
regardless of distance, while the appeal to patients is that it gives
them a greater access to health care. Naturally, both groups prefer
the face-to-face consultation whenever possible, but consultations
can sometimes be offered through a form of telemedicine, which is
more convenient, cheaper, less time-consuming and may be
equally satisfactory for both parties. Furthermore, telemedicine
may reduce the patient’s travelling time and absence from work,
thereby decreasing the overall societal costs.
Given the current situation facing patients and health providers,
and the enormous possibilities offered by the internet, we
developed a telemedicine service to complement standard care.
Specifically, this involved a telecare follow-up for stable HIV-
infected patients in the chronic phase of their disease. The present
study evaluate the home care provided by this telemedicine system
called Virtual Hospital, comparing standard care received by
HIV-infected patients with Virtual Hospital care. The objective of
the study is to demonstrate that Virtual Hospital could improve
and facilitate the access of the patients to the health system without
any deleterious effect on their care. The technical structure of the
system has already been published in several telemedicine journals
[31,32].
Methods
An open-label, two-arm, prospective randomised study was
performed between January 2005 and December 2007 in a
university hospital in Barcelona. Participants were 3500 HIV
outpatients. The protocol for this trial and supporting CONSORT
checklist are available as supporting information; see Checklist S1
and Trial Protocol S1.
The main goals were the definition, development, clinical
routine installation and evaluation of a telemedicine service that
compares standard care with telecare follow-up for stable HIV-
infected patients in the chronic phase of their disease. The study
was approved by the local Human Research Ethics Committee.
Patients signed written informed consent and were randomised
(with balanced randomization [1:1] through a computer generated
randomization list without any restriction) to either: Arm I, where
they were monitored virtually via the internet during the first year
of follow-up; or arm II, where they were monitored in the day
hospital via standard care. After one year of follow up, patients
switched their care to the other arm.
Standard Care in a stable HIV infected adult consists firstly in
to perform a blood test (to assess biochemical parameters, CD4 T
cells, HIV-1 viral load) 15 days before the day of consultation in
the Infectious Diseases Day Care Hospital (laboratory needs 2
weeks to have all the results of the blood test performed). Secondly,
the infectious disease physician during consultation, checks the
analysis, asks about any clinical change and expends antiretroviral
prescriptions if the patient is treated. Thirdly, patient goes with the
antiretroviral prescription to the hospital Pharmacy to perform a
visit with the pharmacist to check antiretroviral compliance and
finally to collect the drugs. The patient repeats this clinical routine
every 3–4 months.
The telecare system, Virtual Hospital, offered integrated online
patient monitoring by a multidisciplinary care team (nine
infectious diseases specialists, three nurses, one psychologist, one
psychiatrist, three pharmacists and one social worker), allowing the
patient to be remotely followed-up by these professionals and have
access to their own clinical and pharmaceutical files. See test web
http://web.gbt.tfo.upm.es/clinic/login.asp.
Inclusion criteria were stable patients (CD4 .250 cells/mm3
during at least the three months prior to inclusion to the study)
who had access to a computer and to broadband. No other specific
demographics (risk groups, educational level and nationality) or
clinical characteristics (hepatitis B or C coinfection) were
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considered selection criteria. Exclusion criteria were HIV-infected
adults with current therapeutic failure (defined by detectable viral
load on treatment or CD4 cell count ,250 cells/ml), tumours,
opportunistic infections, or pregnant women.
The architecture of this web-based system had two parts. The
first was the hospital infrastructure, where we added our server to
the existing demilitarised zone (DMZ) of the hospital, which was
protected by a firewall and integrated into the hospital’s
information system network. Health professionals accessed this
server via the hospital’s intranet. The second part was the home
infrastructure, where the patient accessed the server via a basic
broadband connection and, for security reasons, through a virtual
private network (VPN) (Figure 1). Of critical importance in the
system was the connection of the server with three databases. The
Virtual database was the new database created for the telemed-
icine system, where the data of patients involved in the trial were
stored. This database was filled and synchronised with the HIV/
AIDS database, which the Infectious Diseases Service of the
Hospital Clinic has been using over the last twenty years; this
database includes the records of over 5,000 HIV/AIDS patients.
Finally, the server was also connected to the pharmacy database,
where all the available drugs and data related to antiretroviral
compliance were recorded.
The graphical interface was carefully designed in order to make
it user friendly for both professionals and patients. Another main
goal was to develop a low-cost system so as to enable an increased
number of patients to be offered such care in the future. This is
why low-cost, home web cams and broadband were some of the
chosen technologies for the implementation. Security was one of
the most carefully designed aspects of the project, mainly because
of its experimental nature and due to the characteristics of the
disease in question. As well as securing the communications, via
VPN tunnelling, patient data were also encrypted and all personal
identification data were removed. A completely separate tool was
developed outside the web system, so that only the system
administrator would have access to it. All access to the system was
monitored, and the system automatically sent an alert e-mail to the
technical manager in the event of recurrent access. More technical
information about Virtual Hospital has been previously reported
[31,32].
Virtual Hospital offered four main services: Virtual Consulta-
tions, Telepharmacy, Virtual Library and Virtual Community.
Virtual consultations had two levels: first, appointments/consulta-
tions conducted via videoconferencing; and second, chat sessions
or message exchanges for emergency or off-schedule consultations.
During any of these sessions the Electronic Health Record was
available to both professionals and patients (see Figure 2).
However, whenever patients wish it, in addition to the virtual
consultations they might have an in-person consultation with the
health professionals. It should be noted that psychological and
social data were also integrated into the patients’ records. An
electronic diary was also available so that at the end of the
appointment, the patient and the professional could set a time for
the next one.
Telepharmacy allowed the pharmacist to receive electronic prescrip-
tions, to perform virtual consultations about compliance, adverse
events or interactions, and to send the antiretroviral medication to the
patient’s home by courier. The standard care in our centre is that
patients take their antiretroviral prescriptions to the hospital
pharmacy, where the pharmacist sees the patient, checks whether
he/she is having any problems with treatment, and dispatches the
drugs (in Spain antiretroviral drugs are given out exclusively in
hospital pharmacies). The telepharmacy system enabled patients to
track the evolution of their treatment on charts and consult basic
information regarding the available antiretroviral drugs. The new
process and the telepharmacy system are shown in Figure 3.
Virtual library stored validated information about HIV as links to
other web pages, for both patients and professionals. All links were
categorised by their type of source and were included in different
groups according to the subject they referred to.
Figure 1. Architecture of the Virtual Hospital. The architecture of this web-based system has two parts. The first was the hospital infrastructure,
where we added our server to the existing demilitarised zone (DMZ) of the hospital, which was protected by a firewall and integrated into the
hospital’s information system network. Health professionals accessed this server via the hospital’s intranet. The second part was the home
infrastructure, where the patient accessed the server via a basic broadband connection and, for security reasons, through a virtual private network
(VPN).
doi:10.1371/journal.pone.0014515.g001
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Virtual community provided space to exchange information about
the disease and the project, as well as to share opinions or
comment on articles and news items. The information offered by
this tool differed according to the user (i.e. healthcare professional
or patient). Exclusive to professionals was the clinical session
option, where they could share opinions about the cases they were
responsible for at the time.
A brief twenty-minute introduction to the system’s functioning
was offered to both professionals and patients prior to starting the
study. An external company was hired to help patients with any
Figure 2. Electronic Health Record. A. This figure shows the Virtual Consultation menu, where users select appointments conducted via standard
care, videoconferencing, chat sessions or message exchanges. An electronic diary is also available so that at the end of the appointment, the patient
and the professional could set a time for the next one. B. Here it shows an example of a teleconference appointment. Electronic Health Record
contains demographic, epidemiological and clinical data (Hepatitis B or C coinfections; CD4 cell count and HIV-1 plasma viral load evolution; HAART-
compliance and tolerance; comments of the infectious diseases physician) and is available to both professionals and patients during any of the
sessions.
doi:10.1371/journal.pone.0014515.g002
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technical problems involving hardware or software (patients had a
telephone number to call in such cases). This company resolved
most of the problems by telephone, but when necessary a
technician went to the patient’s house.
The technical performance of Virtual Hospital was evaluated by
both professionals and patients. Validated questionnaires were
used to assess different aspects of the system, with items being
rated on a five-point scale, from 1 for the most negative appraisal
(‘‘Not appropriate/Totally disagree’’) to 5 for the most positive one
(‘‘Very appropriate/Totally agree’’). Parameters regarding access,
organisation of the system, the need for training, reliability,
usability, acceptance, usefulness and satisfaction were also
evaluated.
The Virtual Hospital was also evaluated in terms of its clinical
performance, assessing the impact on HIV clinical parameters
[CD4 cell count, viral load (VL), opportunistic infections, death],
the need to start combined AntiRetroviral Treatment (cART) and
cART-compliance throughout the study follow-up. Adherence was
evaluated at each clinical consultation by monitoring pharmacy
refills and through self-reports and was considered high if the
patients take more than 90% of the scheduled medication [33].
Quality of life was evaluated through a questionnaire that has
been validated in HIV patients, the Mini International Neuro-
psychiatric Interview (MINI) [34,35]. This assessed various aspects
including mental and physical health, cognitive and social
functioning, energy levels and vitality, perceived social support,
sleep and sexuality. Scores were standardised on a scale from 0 to
100, where 0 corresponds to better quality of life and 100 to a
worse one.
Psychological and emotional Impact was evaluated using several
validated screening questionnaires: the Hospital Anxiety and
Depression (HAD) Scale [36,37] to measure anxiety and
depression, Goldberg’s General Health Questionnaire (GHQ-28)
[38,39] to screen for symptoms of psychopathology, and the
Psychosocial Adjustment to Illness Scale (PAIS) [40] to measure
the impact of a medical condition on general psychosocial
functioning.
A qualitative statement about health services utilization in the
study population, was registered in one of the questionnaires that
patients field. There were two questions (question 7 and 9)
addressing this issue. Question 7 was: How many times per year,
do you consult the following health care providers? (7.1–7.3
Infectious Diseases Unit, 7.4 Pharmacy, 7.5 Social Work, 7.6
Psychiatry, 7.7 Primary Care, 7.8 Others). The answers were:
never, one or two per year, each three or four months, each two
months, each month, more than once per month. Question 9 was:
How often has consulted to the following health care providers in
the last three months? (Excluding Virtual Consultations) (9.1–9.3
Infectious Diseases Unit, 9.4 Pharmacy, 9.5 Social Work, 9.6
Psychiatry, 9.7 Primary Care, 9.8 Others). The answers were:
never, ever, several times, once a month, more than once a month.
Quantitative characteristics were described as medians and the
interquartile range (IQR), while qualitative data were given as
frequencies and percentages. Laboratory parameters were com-
pared using a Wilcoxon signed-rank test. Intra-individual changes
in these parameters were compared for the period monitored by
Virtual Hospital versus the period involving standard care (intra-
arm or intra-individual variations), and variability between arms at
the end of the two-year follow-up was also compared (inter-
individual variations). All statistical analyses were performed using
SPSS version 15.0.1. Patients were analyzed in the groups to
which they were randomly assigned and a per-protocol analysis
was conducted.
Sample size calculations (using McNemar’s test of paired
proportions with a significance level of 5%) showed that 77
patients would have 80% power in detecting differences of 25%
when the expected proportion of discordant pairs was 35%. The
selection of this difference is consistent with other studies that
found that non-adherence was associated with poorer virological
outcomes [41–44]. With an estimated lost-to-follow-up rate of
10%, the total sample size required would be 90 patients.
Results
Initially, 91 patients were assessed for eligibility, but four were
excluded due to a lack of broadband, while a further four declined
to participate. Of the remaining 83 randomised patients, 42 were
monitored during the first year through Virtual Hospital (Arm I)
and 41 through standard care (Arm II). Patients switched their
care arm in year two of the study. Baseline characteristics of the
patients were well-balanced between the arms (see Table 1).
Overall, 93% (n = 77) of the cohort had an active working life and
38% (n = 32) had a university degree. A similar number of patients
(n = 46, 55% of the overall cohort) were receiving antiretroviral
therapy at baseline (see Table 1). Over the two years of follow-up,
seven patients (8%) discontinued the study: two were lost to follow-
up (one left the country and one was whereabouts unknown), two
left the Virtual Hospital because they disapproved of the system,
two developed tumours (one non-Hodgkin lymphoma and one
hepatocellular carcinoma), and one patient was killed in a traffic
accident (see patient availability in Figure 4). Overall, therefore, 76
patients (92%) completed the study.
Technical evaluation
Questionnaires submitted by patients (n = 76) revealed a high
level of technical satisfaction with the system after one year of
Virtual Hospital care (Table 2). Overall, 85% of patients (n = 65)
considered that Virtual Hospital improved their access to clinical
data, as compared with standard care, and they felt comfortable
with the videoconference system. The system was rated by 82%
(n = 62) of patients as an easy way to communicate among users.
The same questionnaires were also completed by professionals
(n = 18), with similar results (data not shown).
Clinical evaluation
No opportunistic infections were reported. Regarding the
immunologic evaluation there were no intra-individual (data not
shown) or inter-individual differences over time in CD4 cell counts
as monitored through Virtual Hospital versus standard care (See
Table 3).
Changes in viral load were also similar within individuals (data
not shown) and between arms when comparing the periods for
Virtual Hospital and standard care (See Table 3). Patients on
treatment continued to have an undetectable viral load throughout
the study period in both arms except 1 patient in arm II.
Figure 3. Telepharmacy. A. Telepharmacy allows the pharmacist to receive electronic prescriptions, to perform virtual consultations about
compliance, adverse events or interactions, and to send the antiretroviral medication to the patient’s home by courier. B. This figure shows how
professionals track patient’s HAART-history. C. In this section, the patients can also visualise the evolution of their own treatments on charts and
consult basic information on the antiretroviral drugs available.
doi:10.1371/journal.pone.0014515.g003
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Table 1. Baseline characteristics of the patients.
CATEGORY SUBCATEGORY Cohort Arm I Arm II P
N 83 42 41
Age* (years) 37 (34–43) 37 (34–43) 37 (34–43) 0.9
Gender** Male 72 (87) 36 (86) 36 (88) 0.56
Female 11 (13) 6 (14) 5 (12)
Risk Group** HMS 56 (68) 25 (60) 31 (76) 0.36
HTS 20 (24) 13 (31) 7 (17)
DU 7 (8) 4 (9) 3 (7)
Nationality** Spanish 66 (79) 31 (74) 35 (86) 0.20
Other 17 (21) 11 (26) 6 (14) 0.20
Educational level** Primary school 10 (12) 5 (12) 5 (12) 0.97
Secondary school 41 (49) 20 (48) 21 (51) 0.12
University 32 (38) 17 (40) 15 (37) 0.15
Employment status** Unemployed 6 (7) 3 (7) 3 (7) 0.97
Working 77 (93) 39 (93) 38 (93) 0.12
Disabled 0 0 0 0.15
Hepatitis C** 10 (12) 5 (12) 5 (12) 0.72
Hepatitis B** 9 (11) 3 (7) 6(15) 0.17
CD4+ T cells (cells/mm3)* 602 (471–726) 585 (461–738) 636 (511–718) 0.66
Log10VL (copies/ml)**** 2.79 (0.14) 2.79 (0.22) 2.90 (0.20) 0.40
Treatment ** 46 (55) 24 (57) 22 (54) 0.52
P for comparison between arm I and II. *Median (IQR),
**(n, %),
***(n, % of patients on treatment),
****Mean (SE). HMS: Homosexual. HTS: Heterosexual. DU: Drug users.
doi:10.1371/journal.pone.0014515.t001
Figure 4. Patient availability. 91 patients were assessed for eligibility, but four were excluded due to a lack of broadband, while a further four
declined to participate. Of the remaining 83 randomised patients, 42 were monitored during the first year through Virtual Hospital (Arm I) and 41
through standard care (Arm II). Patients switched their care arm in year two of the study. Over the two years of follow-up, seven patients (8%)
discontinued the study: two were lost to follow-up (one left the country and one was whereabouts unknown), two left the Virtual Hospital because
they disapproved of the system, two developed tumours (one non-Hodgkin lymphoma and one hepatocellular carcinoma), and one patient was
killed in a traffic accident. Overall, 76 patients (92%) completed the study.
doi:10.1371/journal.pone.0014515.g004
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Twenty-three patients (28%) switched antiretroviral therapy
during the study follow-up. Therapeutic changes were due to:
simplification (in 15 patients); because of side events related to
medication (in 6 patients); virologic failure (in 1 patient) and in 1
patient because of interrupted manufacture of the antiretroviral
being taken.
6 patients (7%) started cART throughout the study. cART
switching and the need to start cART was similar between arms
(Table 3).
cART-compliance was high (more than 90%) and was similar
within individuals (data not shown) and between arms during the
two years of follow-up (Table 3).
Quality of life and Psychological and emotional
evaluation
Quality of life assessment did not shown any difference between
arms during the two years of the study (Table 3). In addition, none
of the psychological tests performed (HAD scale, Goldberg Health
Questionnaire, Psychosocial Adjustment to Illness Scale) observed
differences between arms during follow-up (Table 3)
Health services assessment
Regarding the consultation to the health care providers (n = 76),
most of the patients (78%, n = 59) performed a consultation every
four months to the Infectious Disease Unit and most of the
remaining patients twice a year. About sixty percent of patients
(n = 46) consulted Pharmacy every 4 months and 33% (n = 25) of
the patients never did it (those who are untreated). 76% (n = 58) of
the patients never used Psychiatry services. The utilization of these
stable patients to the Social Work services was very low. Primary
care physicians and other health care providers were never
consulted by 45% (n = 34) and 64% (n = 49) of the patients,
respectively (See Table 3). There were no differences in health
services utilization between study arms during study follow-up.
Table 2. Technical evaluation by patients of the Virtual Hospital.
CATEGORY SUBCATEGORY Patients*
N 76
Access The system meets my needs 84
The data are easy to manage 88
It is easy to input data 78
The data are presented in a good way 82
It is easy to correct the data 65
Managing the data is quick 65
The system improves access to clinical data 85
Organisation The appointments process works well 82
The system for dispatching medication works well 64
The virtual library is useful 67
The virtual community is useful and easy to use 50
I feel comfortable with the videoconference system 85
The system improves communication between users 82
Training The period and type of training has been useful 80
I have needed to consult additional documentation about the system 17
I learned easily to use the system 81
Reliability Virtual Hospital is secure and stable 83
I have needed technical support 15
Technical problems were resolved quickly 73
I have lost data due to system errors 5
Usability Navigating around the system is quick 93
Collaboration between health workers has changed 50
Acceptance The system is acceptable 81
Usefulness The system is useful 84.6
Satisfaction I am satisfied with Virtual Hospital 69
I feel comfortable with the system 90
I like Virtual Hospital 86
Virtual Hospital improves my daily life 74
I would like to use the system in the future 85
The relationship with healthcare professionals is easier 68
Virtual Hospital enables me to save time and money 85
Questionnaire items were rated from 1 (most negative) to 5 (most positive).
*Proportion of patients who gave the two highest ratings (4 = ‘‘appropriate/agree’’, or 5 = ‘‘Very appropriate/Totally agree’’).
doi:10.1371/journal.pone.0014515.t002
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Excluding Primary care, all the consultations performed not only
infectious diseases specialists, but pharmacists, social worker and
psychiatrists are integrated in the multidisciplinary care team of
Virtual Hospital, allowing the patient to be remotely followed-up
by these professionals too.
On the other hand, analyzing the health services utilization out
of Virtual Consultations 69% (n = 52), 74% (n = 56) and 86%
(n = 65) of the patients always consulted the Infectious diseases
Unit, Pharmacy and Psychiatry services, respectively, using the
virtual system. Again, similar results were observed between study
groups.
Costs Evaluation
Regarding budget to develop this telemedicine system, there
were costs related to equipment in the hospital infrastructure.
Hardware and software Virtual Hospital development cost was
50.000 euros. An external company was hired to help patients with
any technical problems involving hardware or software installa-
tion, training or maintenance of the system with a cost of 70 euros
per patient/year. Posting service cost, used eventually for
medication delivery to patient home, was about 50 euros per
patient/year. Home infrastructure (computer and broadband
connection) was supported by patients.
Table 3. Study findings.
CATEGORY SUBCATEGORY Cohort Arm I Arm II P
N 83 42 41
CLINICAL EVALUATION SUBCATEGORY Cohort Arm I Arm II P
CD4+ T cells (cells/mm3)* Month 12 712 (32) 738 (46) 796 (50) 0.4
Month 24 751 (38) 688 (43) 706 (58) 0.2
Log10VL (copies/ml)* Month 12 2.76 (0.13) 2.58 (0.19) 2.40 (0.19) 0.3
Month 24 2.57 (0.14) 2.92 (0.20) 2.74 (0.21) 0.4
Need to start HAART ** Month 12 3 (4) 1 (1) 2 (2)
Month 24 3 (4) 0 (0) 3 (4)
cART switching** Month 12 16 (19) 8 (10) 8 (10)
Month 24 7 (8) 4 (5) 3 (4)
cART compliance* Month 12 93.4 (1.2) 94.5 (1.5) 95.1 (1.2) 0.3
Month 24 94.5 (0.9) 91.9 (1.9) 93.6 (.3) 0.4
Tumors ** Month 12 2 (2) 0 (0) 2 (2)
Month 24 0 (0) 0 (0) 0 (0)
Deaths ** Month 12 1 (1) 0 (0) 0 (0)
Month 24 0 (0) 0 (0) 0 (0)
Quality of life assessment** Month 12 29.0 (2.3) 30.4 (3.4) 32.0 (3.8) 0.5
Month 24 32.1 (2.6) 27.2 (2.6) 32.1 (3.7) 0.9
PSYCHOLOGICAL EVALUATION SUBCATEGORY Cohort Arm I Arm II P
HAD scale *** Month 12 17.2 (0.4) 18.1 (0.6) 16.0 (0.5) 0.1
Month 24 17.5(0.6) 16.9 (1.0) 18.3 (0.8) 0.2
Goldberg Questionnaire*** Month 12 4.9 (0.9) 5.9 (1.6) 3.6 (1.0) 0.8
Month 24 5.6 (1.3) 5.9 (1.8) 5.4 (1.8) 0.6
PAIS scale*** Month 12 66.5 (0.7) 67.3 (0.9) 66.7 (0.9) 0.5
Month 24 66.4 (1.1) 67.0 (0.9) 65.8 (2.0) 0.8
HEALTH SERVICES UTILIZATION SUBCATEGORY Cohort Arm I Arm II P
Infectious Diseases Unit*** Month 12 (4M/6M) 78%/19% 78%/17% 70%/20% 0.6
Month 24(4M/6M) 79%/18% 79%/18% 67%/29%
Pharmacy*** Month 12 (4M/0) 60%/33% 49%/32% 59%/34% 0.1
Month 24 (4M/0) 59%/34% 48%/33% 58%/37%
Primary Care*** Month 12 (0/1–4) 45%/43% 45%/42% 43%/46% 0.3
Month 24 (0/1–4) 45%/44% 45%/42% 42%/46%
Other health providers*** Month 12 (0/1–2) 65%/24% 51%/32% 73%/20% 0.3
Month 24 (0/1–2) 64%/24% 51%/33% 75%/17%
P for comparison between arm I and II.
*Mean (SE).
**(n, %). cART compliance: 93.4 means that patients took the 93.4% of the scheduled medication.
***(%). 4M: every 4 months. 6M: twice a year. 0: Never used. 1–4: Used from 1 to 4 times a year. 1–2: Used from 1 to 2 times a year.
doi:10.1371/journal.pone.0014515.t003
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Discussion
We report the results of a prospective randomised study using a
new model of multidisciplinary home care for chronic and stable
HIV patients. The approach is based on a telemedicine platform,
the Virtual Hospital, which covers the entire process of patient
care (consultations, medical care, psychological and social support,
medication, quality of life) via the internet and allows patients
access to their own file. The study shows that Virtual Hospital
constitutes a feasible, fairly satisfactory and safe tool for the clinical
care of stable HIV-infected patients, and it has no deleterious
effect on HIV clinical parameters, antiretroviral compliance,
quality of life, or psychological and emotional status.
Patients were very satisfied with the system, as it has been
showed by the satisfaction questionnaire and the low rate of
withdrawal [76 from the 91 patients randomized ended the study
(83%)]. In addition, when this study ended (december 2007),
patients involved in it express their willingness to continue on
Virtual Hospital and from then until now Virtual Hospital is being
used as a routine work tool of the Infectious Disease Unit of the
Hospital. Nowadays, there are round 200 patients cared of their
HIV infection with such internet service. Otherwise being cared
via Virtual hospital has not increased health resources utilization
because of most of patients (69%, n = 52), out of Virtual
consultations has never consulted to the Infectious diseases Unit
even though almost a thirty percent of the study population (23
patients, 28%) has switched their antiretroviral medication,
certainly one of the more difficult points in HIV management.
Telemedicine in HIV has been assessed in low-resource settings,
both as an additional tool to help in the routine care of HIV-
infected patients and for the training and education of healthcare
providers [45]. Teleconferences, calls by mobile phones and e-
health systems have all been used to support comprehensive HIV
treatment programmes. In developed countries, telemedicine has
been used as a tool to solve communication problems, as a
prevention strategy for gay men [46] or special populations such as
Latinos [47] or African-Americans [48], and to improve health
outcomes including antiretroviral adherence [49], access to care
for HIV-infected prisoners [50], clinical monitoring of highly
treatment-experienced HIV-infected patients [51], cardiovascular
risk assessment electrocardiograms at distance [52], and smoking
cessation interventions [53]. The main innovation of our web-
based system is that, to our knowledge, this is the first time that a
telemedicine approach has enabled the whole range of HIV care
to be offered to stable and chronic patients.
New procedures and improvements in telemedical patient
education could support self-management and self-care of this
disease through tools such as access to electronic medical records,
availability of constant information updates, and the development
of a custom online community of patients. The system is also
scalable for future functionality and enables the integration of both
information and services, which could facilitate cooperation
between different professionals (primary and specialist care),
creating units to improve the care of HIV infection.
Our platform provides a technical infrastructure that can
simultaneously support telemedicine programmes for different
chronic diseases and patients with different risk levels. Indeed,
platforms like the Virtual Hospital are destined to play a major
role in facilitating new strategies for chronic care management, for
example, by means of out-of-hospital follow-up, patient empow-
erment and care coordination, thereby improving patient care
without an associated rise in costs. Several chronic diseases such as
diabetes, congestive heart failure or chronic obstructive pulmonary
disease have all used telemedicine with similar findings [6–25].
The world’s population is aging. As we age, the incidence and
prevalence of chronic illness continue to rise, and elderly patients
typically have multiple chronic diseases. The HIV-infected popula-
tion follows this same trend, but the fact that the rate of new HIV
infections has remained stable since 1995 [54] means the effect is
worsened by the growing number of HIV-infected patients. The
Hospital Clinic in Barcelona receives about 250 new HIV-infected
patients each year. This increase, coupled with the drastic decrease in
mortality due to current antiretroviral treatments, produces a
significant annual increase in the care burden (around 10%, with
an annual increase of 1000 new appointments in the Day Hospital).
Given the current situation facing not only patients (who are likely to
remain clinically stable for years) but also health providers, it is
important to consider the enormous potential of the internet. Here
the Virtual Hospital has been shown to be a feasible and safe tool for
providing multidisciplinary home care to chronic HIV patients.
Although our study did not set out to measure the economics of
study arms, to assist the reader’s understanding of the importance
of the work to health care providers and to society as a whole in
implementing the new system, we have made a qualitative
statement about whether, for example, cost savings could be
expected with the new system. The population of this study for
clinical monitoring of their infection, regardless of belonging to a
study arm or another, required to perform a blood test, a medical
visit and eventually, antiretroviral treatment.
Regarding costs of blood tests, both direct costs (unitary price of a
standard blood analysis, a CD4 test and an HIV-1 RNA test) and
indirect costs (transport costs and time invested to reach the
laboratory, productivity cost, absenteeism, quality of life and
psychosocial status) should be the same for both study arms, because
this study contemplated to perform the blood tests on the same site.
Costs of medical consultations for the health system, as the
estimated unit cost for an outpatient visit with an HIV specialist care
provider would not be modified in both types of cares. However,
indirect costs regarding the time that professionals spend on each
visit, the resources on space, infrastructure and personnel needed for
a consultation presumably would be lower in the telemedicine arm
and higher the communication effectiveness between patients and
professionals. For example, the median time of a consultation via
telemedicine is usually 5 minutes, compared with 20 minutes of
standard visits; virtual consultation can be made at any office with a
computer connected to the Internet (it is not necessary a day care
hospital unit investing large areas, technical infrastructure and
staffing complex), the median time to response to a consultation in
the virtual branch is usually 24 hours, thus minimizing possible
deleterious effects that any delay in communication could cause on
clinical management. In parallel the costs of medical visits for
patients, both direct costs (transportation to hospital) and indirect
costs would be diminished in the telematic care among others by
reducing travel time or waiting time for visits and medications (the
median Hvirtual waiting time consultation is about 10 minutes
compared with 60–90 minutes of waiting time at standard care).
The direct costs of antiretroviral medicaments should also be the
same in both cares, although indirect costs to obtain antiretrovirals
in the virtual arm should be lower than in the standard care. In the
standard care arm, the patient must go to the hospital pharmacy to
pick up the medication, which would include additional costs in
transportation and working-time losses as previously mentioned. In
the virtual arm, either because the medication arrives directly to
patient’s home by courier or because it is the patient who chooses
the best time to pick up medication when receives virtual
antiretroviral prescription, indirect costs would be lower.
Then to summarize, out an initial software development
investment, the Virtual Hospital cost per patient/year was 120
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euros (or 70 euros without posting service cost medication delivery
to patient home). Taking into account, the mentioned advantages
that implementing this new model would provide in terms of direct
and indirect costs of medical consultations and antiretroviral
prescriptions for the health system and for patients, we believe that
Virtual Hospital could be moreover cost-effective.
The study shows that Virtual Hospital constitutes a feasible,
fairly satisfactory, safe and a low cost tool for the clinical care of
stable HIV-infected patients and it has no deleterious effect on
HIV clinical parameters and health services utilization.
Telemedicine should be considered an appropriate support service
for the entire management of chronic HIV infection, is likely to prove
extremely useful in settings with poor access to the health system.
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